Established through a $1,000,000 gift from Fujifilm to Harvard Medical School, the program will advance education and research in the field of translational medicine.
UNIVANTS of Healthcare Excellence Award winners have demonstrated how integrated care, including in the diagnostic laboratory, can transform the delivery of healthcare for value-based care
Researchers take first step to understanding of the potential impact of the microbiome on amyotrophic lateral sclerosis
Paper published in Frontline Gastroenterology outlines new quality standards and benchmarking framework for inflammatory bowel disease
Drop by and see SelectScience on booth #724 at this year's AACC conference in Anaheim, California, from August 4-8
Access to innovative diagnostic solutions will contribute to the World Health Organization’s infectious disease elimination goals
Startup uses brain stimulation headset and therapy app to treat depression
Rigaku Oxford Diffraction is exhibitor and sponsor at the 2019 ACA Annual Meeting in Covington
The off-the-shelf diploid library includes over 2,800 single clonal knockout (KO) cell lines, targeting over 2,600 genes
Joint chemical identification technologies are integrated into a single handheld solution to deliver advanced automated explosive detection and chemical analysis capabilities
Arcis technology is designed to enable stabilization of microRNA biomarkers for early disease diagnosis
Understanding how insects navigate using the sun and daylight has potential to aid robot guidance system development
New industrial solutions from the partnership include in-line X-ray semiconductor metrology with microfocus mirror optics
The 7th International Conference on Advanced Applied Raman Spectroscopy attracted top scientists across the field
Decision enables human identification labs to upload genetic profiles to national database using Applied Biosystems Precision ID panel for mitochondrial DNA analysis
Deal brings single-cell genomics to China and accelerates Mission Bio’s mission to predict and prevent cancer relapse on a global scale
New partnership to advance Nosopharm’s lead candidate to clinical stage
Phase 1 trial scheduled for early 2020 will be first CAR-T cell therapy clinical trial to employ SMARTvector technology
